0000950138-21-000176.txt : 20210303
0000950138-21-000176.hdr.sgml : 20210303
20210303184928
ACCESSION NUMBER: 0000950138-21-000176
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210301
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kinard David S
CENTRAL INDEX KEY: 0001752439
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38661
FILM NUMBER: 21711383
MAIL ADDRESS:
STREET 1: 13543 WATER CREST DRIVE
CITY: FISHERS
STATE: IN
ZIP: 46038
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elanco Animal Health Inc
CENTRAL INDEX KEY: 0001739104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825497352
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
BUSINESS PHONE: 877-352-6261
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-03-01
0001739104
Elanco Animal Health Inc
ELAN
0001752439
Kinard David S
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
GREENFIELD
IN
46140
0
1
0
0
See Remarks
Common Stock
2021-03-01
4
A
0
6717
0
A
78499
D
Common Stock
2021-03-01
4
F
0
483
33.65
D
78016
D
Common Stock
2021-03-02
4
F
0
573
32.34
D
77443
D
Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 1, 2021, one-third vesting on March 1, 2022, one-third vesting on March 1, 2023, and the remaining vesting on March 1, 2024.
Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan.
Executive Vice President, Human Resources, Corporate Affairs and Administration
EXHIBIT LIST - Exhibit 24 - Power of Attorney for David Kinard
/s/ David S. Kinard
2021-03-03
EX-24
2
kinardpoa_032021.txt
POWER OF ATTORNEY FOR DAVID KINARD
POWER OF ATTORNEY
March 3, 2021
Know all by these present that the undersigned hereby constitutes and
appoints Catherine Powell and Jinee L. Majors, with full power of substitution,
the undersigned's true and lawful attorneys-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of Elanco Animal Health Incorporated
(the "Company") or as a stockholder of the Company or as a trustee of a
stockholder of the Company, Forms 3, 4, and 5 and Schedules 13D or 13G,
including amendments thereto, relating to the securities of the Company in
accordance with Section 16(a) of the Securities Exchange Act of 1934 and the
rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form 3, 4,
or 5 or Schedule 13D or 13G, complete and execute any amendment or amendments
thereto, and timely file such form with the United States Securities and
Exchange Commission and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of each such attorney-in-fact, may be of
benefit to, in the best interest of, or legally required by, the undersigned,
it being understood that the documents executed by each such attorney-in-fact
on behalf of the undersigned pursuant to this Power of Attorney shall be in
such form and shall contain such terms and conditions as each such attorney-in-
fact may approve in each such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that each such attorney-in-
fact, or each such attorney-in-fact's substitute or substitutes, shall lawfully
do or cause to be done by virtue of this Power of Attorney and the rights and
powers herein granted. The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, is not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with, or liabilities that may arise
under, Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 or Schedules 13D or
13G with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in
a signed writing delivered to the foregoing attorneys-in-fact.
This Power of Attorney shall not revoke any powers of attorney previously
executed by the undersigned. This Power of Attorney shall not be revoked by any
subsequent power of attorney that the undersigned may execute, unless such
subsequent power of attorney specifically provides that it revokes this Power
of Attorney by referring to the date of the undersigned's execution of this
Power of Attorney.
[The remainder of this page has been intentionally left blank]
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the day and year first above written.
David Kinard
________________________
Signature
David Kinard
________________________